Reducing Chronic Obstructive Pulmonary Disease Hospital Readmissions. An Official American Thoracic Society Workshop Report.

"Author Disclosures: V.G.P. received research support from Novartis; served as a consultant for Roundglass. D.H.A. served on a data and safety monitoring board for Novartis; as a consultant for Gilead. J.B. served as a consultant for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Grifols, and Novartis; received research support from Aerocrine, AstraZeneca, Boehringer Ingelheim, the Canadian Institutes of Health Research, the Canadian Respiratory Research Network, GlaxoSmithKline, and Grifols. M.T.D. served as a consultant and received research support from AstraZeneca, Boehringer Ingelheim, Boston Scientific, GlaxoSmithKline, and PneumRx/BTG; as a consultant for Genentech and Quark Pharmaceuticals; on a data safety and monitoring board for GlaxoSmithKline; received research support from Novartis, Pulmonx, and Yungjin. J.A.K. served as a consultant for CVS/Caremark, eMAX Health, Phillips Respironics, and UpToDate; on a data and safety monitoring board for Sanofi. F.C.S. served on an advisory committee for Boehringer Ingelheim, Circassia, and PneumRx; as a consultant for BTG International; received research support from Boehringer Ingelheim, BTG International, Circassia, PneumRx, Pulmonx, and Spiration. A.S.G., R.A.M., J.S., and L.C.F. reported no relationships with relevant commercial interests."

"Author Disclosures: V.G.P. received research support from Novartis; served as a consultant for Roundglass. D.H.A. served on a data and safety monitoring board for Novartis; as a consultant for Gilead. J.B. served as a consultant for AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Grifols, and Novartis; received research support from Aerocrine, AstraZeneca, Boehringer Ingelheim, the Canadian Institutes of Health Research, the Canadian Respiratory Research Network, GlaxoSmithKline, and Grifols. M.T.D. served as a consultant and received research support from AstraZeneca, Boehringer Ingelheim, Boston Scientific, GlaxoSmithKline, and PneumRx/BTG; as a consultant for Genentech and Quark Pharmaceuticals; on a data safety and monitoring board for GlaxoSmithKline; received research support from Novartis, Pulmonx, and Yungjin. J.A.K. served as a consultant for CVS/Caremark, eMAX Health, Phillips Respironics, and UpToDate; on a data and safety monitoring board for Sanofi. F.C.S. served on an advisory committee for Boehringer Ingelheim, Circassia, and PneumRx; as a consultant for BTG International; received research support from Boehringer Ingelheim, BTG International, Circassia, PneumRx, Pulmonx, and Spiration. A.S.G., R.A.M., J.S., and L.C.F. reported no relationships with relevant commercial interests."